2019 Irritable Bowel Syndrome Clinical Trials Guide- Companies, Drugs, Phases, Subjects, Current Status and Outlook to 2025
The global clinical trial report- “2019 Irritable Bowel Syndrome Clinical Trials Study” provides complete list of trials completed, ongoing and planned for Irritable Bowel Syndrome. It presents in-depth analysis of Irritable Bowel Syndrome clinical trials across markets and companies. The research work is for providing complete understanding into trends in Irritable Bowel Syndrome.
The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.
It also segments the Irritable Bowel Syndrome clinical trials by-
The research work is prepared through extensive and continuous research on Irritable Bowel Syndrome trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.
Report Scope and Coverage:
The report covers a key snapshot of trial trends, enrollment trends, success trends, locations and other trends.
It also segments the Irritable Bowel Syndrome clinical trials by-
- Current Trial Status
- Type of the trial
- Sponsor Type
- Enrollment Trends
- Region
- Countries
- Trial Phase
The research work is prepared through extensive and continuous research on Irritable Bowel Syndrome trials from over 1500 sources including company websites, conferences and presentations, scientific journals, country wise and global clinical trial registries, news, health and science departments among others.
Report Scope and Coverage:
- All major trials from 2010 to 2019 and planned trials are included in the report scope.
- Drug candidates currently being researched for administering Irritable Bowel Syndrome patients are identified
- The report includes panorama of Irritable Bowel Syndrome clinical trials across the globe
- Trial Phase, Current Status, Sponsor Type, Location, trial type and Enrollment details are provided
- Companies and universities focusing on Irritable Bowel Syndrome clinical trials are analyzed along with their trial participation (trial title, trial phase and current status)
- Average Enrollment number, insights into enrollment trends, company wise enrollment are included
- Both interventional and observational studies are analyzed
- News and latest developments for the past one year are presented in the report
1. TABLE OF CONTENTS
1.1 List of Figures
1.2 List of Tables
2. EXECUTIVE SUMMARY
2.1 Irritable Bowel Syndrome Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Irritable Bowel Syndrome Clinical Trials by Region
2.2.2 Average Enrollment of Irritable Bowel Syndrome Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Irritable Bowel Syndrome Treatment, 2019
3. REGION WISE IRRITABLE BOWEL SYNDROME CLINICAL TRIALS
3.1 Asia Pacific Irritable Bowel Syndrome Clinical Trials by Country
3.2 Europe Irritable Bowel Syndrome Clinical Trials by Country
3.3 North America Irritable Bowel Syndrome Clinical Trials by Country
3.4 Middle East and Africa Irritable Bowel Syndrome Clinical Trials by Country
3.5 South and Central America Irritable Bowel Syndrome Clinical Trials by Country
4. IRRITABLE BOWEL SYNDROME CLINICAL TRIAL TRENDS
4.1 Start Year wise Irritable Bowel Syndrome Clinical Trials
4.2 Phase wise Irritable Bowel Syndrome Clinical Trials
4.3 Trial Status wise Irritable Bowel Syndrome Clinical Trials
4.4 Trial Type wise Irritable Bowel Syndrome Clinical Trials
5. IRRITABLE BOWEL SYNDROME AVERAGE ENROLLMENT TRENDS
5.1 Average Enrollment in Irritable Bowel Syndrome Trials by Year
5.2 Average Enrollment in Irritable Bowel Syndrome Trials by Phase
5.3 Average Enrollment in Irritable Bowel Syndrome Trials by Status
5.4 Average Enrollment in Irritable Bowel Syndrome Trials by Type of Trial
6. COMPANIES PARTICIPATING IN IRRITABLE BOWEL SYNDROME CLINICAL TRIALS
6.1 Irritable Bowel Syndrome Trials by Sponsor Type
6.2 Irritable Bowel Syndrome Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors
7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS
7.1 Irritable Bowel Syndrome Trials- Phase
7.2 Irritable Bowel Syndrome Trials- Phase
7.3 Irritable Bowel Syndrome Trials- Phase
7.4 Irritable Bowel Syndrome Trials- Phase
8. APPENDIX
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise
1.1 List of Figures
1.2 List of Tables
2. EXECUTIVE SUMMARY
2.1 Irritable Bowel Syndrome Clinical Trials Overview, 2019
2.2 Premium Insights into Clinical Trials
2.2.1 Irritable Bowel Syndrome Clinical Trials by Region
2.2.2 Average Enrollment of Irritable Bowel Syndrome Clinical Trials
2.2.3 Companies participating in Trials
2.2.4 Drugs under Study for Irritable Bowel Syndrome Treatment, 2019
3. REGION WISE IRRITABLE BOWEL SYNDROME CLINICAL TRIALS
3.1 Asia Pacific Irritable Bowel Syndrome Clinical Trials by Country
3.2 Europe Irritable Bowel Syndrome Clinical Trials by Country
3.3 North America Irritable Bowel Syndrome Clinical Trials by Country
3.4 Middle East and Africa Irritable Bowel Syndrome Clinical Trials by Country
3.5 South and Central America Irritable Bowel Syndrome Clinical Trials by Country
4. IRRITABLE BOWEL SYNDROME CLINICAL TRIAL TRENDS
4.1 Start Year wise Irritable Bowel Syndrome Clinical Trials
4.2 Phase wise Irritable Bowel Syndrome Clinical Trials
4.3 Trial Status wise Irritable Bowel Syndrome Clinical Trials
4.4 Trial Type wise Irritable Bowel Syndrome Clinical Trials
5. IRRITABLE BOWEL SYNDROME AVERAGE ENROLLMENT TRENDS
5.1 Average Enrollment in Irritable Bowel Syndrome Trials by Year
5.2 Average Enrollment in Irritable Bowel Syndrome Trials by Phase
5.3 Average Enrollment in Irritable Bowel Syndrome Trials by Status
5.4 Average Enrollment in Irritable Bowel Syndrome Trials by Type of Trial
6. COMPANIES PARTICIPATING IN IRRITABLE BOWEL SYNDROME CLINICAL TRIALS
6.1 Irritable Bowel Syndrome Trials by Sponsor Type
6.2 Irritable Bowel Syndrome Average Enrollment by Sponsor Type
6.3 Subjects Recruited by Leading Sponsors
7 TRIAL SNAPSHOTS- PHASE, TYPE, TITLE, LOCATION, START YEAR, COMPLETION YEAR, RECRUITMENT STATUS, ENROLLMENT, PARTICIPATING COUNTRIES, TRIAL LOCATIONS, COMPANY, DRUGS AND OTHER DETAILS
7.1 Irritable Bowel Syndrome Trials- Phase
7.2 Irritable Bowel Syndrome Trials- Phase
7.3 Irritable Bowel Syndrome Trials- Phase
7.4 Irritable Bowel Syndrome Trials- Phase
8. APPENDIX
8.1 Report Guidance
8.2 Research Methodology
8.3 Abbreviations
8.4 Definitions
8.5 Sources
8.6 Publisher Expertise
LIST OF FIGURES
Figure 1: Irritable Bowel Syndrome Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Irritable Bowel Syndrome Clinical Trials and Enrolment
Figure 5: Europe – Country wise Irritable Bowel Syndrome Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Irritable Bowel Syndrome Clinical Trials and Enrolment
Figure 7: North America – Country wise Irritable Bowel Syndrome Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Irritable Bowel Syndrome Clinical Trials and Enrolment
Figure 9: Irritable Bowel Syndrome Clinical Trials by Phase
Figure 10: Irritable Bowel Syndrome Clinical Trials by Trial Status
Figure 11: Irritable Bowel Syndrome Clinical Trials by Type
Figure 12: Irritable Bowel Syndrome Clinical Trials by Sponsor Type
Figure 13: Irritable Bowel Syndrome Clinical Trials by Leading Sponsors
Figure 14: Irritable Bowel Syndrome Average Enrollment by Phase
Figure 15: Irritable Bowel Syndrome Average Enrollment by Trial Status
Figure 16: Irritable Bowel Syndrome Average Enrollment by Type
Figure 17: Irritable Bowel Syndrome- Average Enrolment by Type of Sponsors
Figure 18: Irritable Bowel Syndrome- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology
Figure 1: Irritable Bowel Syndrome Clinical Trials by Region, 2019
Figure 2: Country wise Clinical Trials, 2019
Figure 3: Country wise Average Enrolment, 2019
Figure 4: Asia Pacific – Country wise Irritable Bowel Syndrome Clinical Trials and Enrolment
Figure 5: Europe – Country wise Irritable Bowel Syndrome Clinical Trials and Enrolment
Figure 6: Middle East Africa – Country wise Irritable Bowel Syndrome Clinical Trials and Enrolment
Figure 7: North America – Country wise Irritable Bowel Syndrome Clinical Trials and Enrolment
Figure 8: South and Central America – Country wise Irritable Bowel Syndrome Clinical Trials and Enrolment
Figure 9: Irritable Bowel Syndrome Clinical Trials by Phase
Figure 10: Irritable Bowel Syndrome Clinical Trials by Trial Status
Figure 11: Irritable Bowel Syndrome Clinical Trials by Type
Figure 12: Irritable Bowel Syndrome Clinical Trials by Sponsor Type
Figure 13: Irritable Bowel Syndrome Clinical Trials by Leading Sponsors
Figure 14: Irritable Bowel Syndrome Average Enrollment by Phase
Figure 15: Irritable Bowel Syndrome Average Enrollment by Trial Status
Figure 16: Irritable Bowel Syndrome Average Enrollment by Type
Figure 17: Irritable Bowel Syndrome- Average Enrolment by Type of Sponsors
Figure 18: Irritable Bowel Syndrome- Enrolment by Leading Sponsors
Figure 19: VPAResearch- Research Methodology
LIST OF TABLES
Table 1: Irritable Bowel Syndrome Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Irritable Bowel Syndrome Clinical Trials and Enrolment
Table 5: Europe – Country wise Irritable Bowel Syndrome Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Irritable Bowel Syndrome Clinical Trials and Enrolment
Table 7: North America – Country wise Irritable Bowel Syndrome Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Irritable Bowel Syndrome Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Irritable Bowel Syndrome Average Enrollment by Phase
Table 15: Irritable Bowel Syndrome Average Enrollment by Trial Status
Table 16: Irritable Bowel Syndrome Average Enrollment by Type
Table 17: Irritable Bowel Syndrome- Average Enrolment by Type of Sponsors
Table 18: Irritable Bowel Syndrome- Enrolment by Leading Sponsors
Table 1: Irritable Bowel Syndrome Clinical Trials Snapshot- 2019
Table 2: Trials by Region, 2019
Table 3: Country wise Clinical Trials and Average Enrolment by Country, 2019
Table 4: Asia Pacific – Country wise Irritable Bowel Syndrome Clinical Trials and Enrolment
Table 5: Europe – Country wise Irritable Bowel Syndrome Clinical Trials and Enrolment
Table 6: Middle East Africa – Country wise Irritable Bowel Syndrome Clinical Trials and Enrolment
Table 7: North America – Country wise Irritable Bowel Syndrome Clinical Trials and Enrolment
Table 8: South and Central America – Country wise Irritable Bowel Syndrome Clinical Trials and Enrolment
Table 9: Clinical Trials by Phase
Table 10: Clinical Trials by Trial Status
Table 11: Clinical Trials by Type
Table 12: Clinical Trials by Sponsor Type
Table 13: Clinical Trials by Leading Sponsors
Table 14: Irritable Bowel Syndrome Average Enrollment by Phase
Table 15: Irritable Bowel Syndrome Average Enrollment by Trial Status
Table 16: Irritable Bowel Syndrome Average Enrollment by Type
Table 17: Irritable Bowel Syndrome- Average Enrolment by Type of Sponsors
Table 18: Irritable Bowel Syndrome- Enrolment by Leading Sponsors
